Securities firms have conducted research on 162 companies in August, with high levels of interest in the electronics and machinery industries. There are promising opportunities for innovative pharmaceutical companies to expand overseas.

Against the backdrop of the current hot A-share market and the gradual disclosure of semi-annual reports by listed companies, securities analysts are conducting non-stop research on listed companies, tracking the latest business changes of companies and adjusting stock ratings. Data shows that since August, securities firms have conducted research on a total of 162 listed companies, covering recent hot industries such as electronics, pharmaceuticals, machinery equipment, and power equipment. Among them, the overseas expansion of pharmaceutical and biotech companies has attracted a lot of attention from securities firms.